Difficult to scale up expensive therapy beyond a point: Kiran Mazumdar-Shaw

CAR-T therapies, previously not available in India, have shown promising results for patients who have exhausted all other means of treatment in a range of blood cancers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RUd6we4
via IFTTT